Synergy CHC Corp. (SNYR) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Synergy CHC Corp. (SNYR) Healthcare & Pipeline Overview

Synergy CHC Corp. provides consumer healthcare, beauty, and lifestyle products, including brain health supplements (FOCUSfactor), lifestyle accessories (Flat Tummy), and anti-aging skincare (Hand MD). The company distributes through retail partnerships, online sales, and television advertising across the United States, Canada, and the United Kingdom.

What Is the Investment Thesis for SNYR?

Synergy CHC Corp. operates in the competitive consumer health and wellness market. With a market capitalization of $1.21M and a negative profit margin of -40.6%, the company faces significant challenges in achieving profitability. Key value drivers include the continued growth of its FOCUSfactor brand in the brain health supplement market and the potential expansion of its Flat Tummy and Hand MD product lines. The company's high gross margin of 66.7% suggests strong pricing power, but operational inefficiencies need to be addressed. Catalysts include potential partnerships with major retailers and successful marketing campaigns. Potential risks include intense competition, changing consumer preferences, and the need for effective brand management. The company's beta of 1.47 indicates higher volatility compared to the market.

Based on FMP financials and quantitative analysis

SNYR Key Highlights

Gross Margin of 66.7% indicates strong pricing power in the consumer health and beauty market.

• Negative Profit Margin of -40.6% highlights significant challenges in achieving profitability and managing operational costs.
• Market Cap of $1.21M reflects the company's small size and potential growth opportunities.
• Distribution network across the United States, Canada, and the United Kingdom provides a broad market reach.
• FOCUSfactor brand represents a key asset in the growing brain health supplement market.

Who Are SNYR's Competitors?

SNYR is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are SNYR's Key Strengths?

Established brand recognition for FOCUSfactor.

• Diverse product portfolio across health, beauty, and lifestyle categories.
• Multi-channel distribution network (retail, online, television).
• High gross profit margin.

What Are SNYR's Weaknesses?

Negative profit margin indicates operational inefficiencies.

• Small market capitalization limits access to capital.
• High beta suggests higher volatility compared to the market.
• Limited geographic presence primarily in the US, Canada, and the UK.

What Could Drive SNYR Stock Higher?

Potential partnerships with major retailers to expand product distribution.

• Continued growth of the FOCUSfactor brand in the brain health supplement market.
• Implementation of digital marketing strategies to enhance online sales.

What Are the Key Risks for SNYR?

Financial-distress signal — its Altman Z-Score of -13.08 sits in the distress zone (elevated bankruptcy risk).

• Inconsistent delivery — missed Wall Street EPS estimates in 3 of the last 7 reported quarters.
• Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
• Intense competition from established players and emerging brands.
• Changing consumer preferences and demand for natural products.
• Negative profit margin indicates operational inefficiencies.
• Economic downturns impacting consumer spending on discretionary items.

What Are the Growth Opportunities for SNYR?

• Expansion of FOCUSfactor Product Line: The brain health supplement market is experiencing significant growth, driven by increasing awareness of cognitive health and the aging population. Synergy CHC Corp. can capitalize on this trend by expanding its FOCUSfactor product line to include new formulations, delivery methods, and targeted solutions for different age groups and cognitive needs. The global brain health supplements market is projected to reach $13.38 billion by 2028. Timeline: Ongoing.
• Strategic Retail Partnerships: Securing partnerships with major retailers in the United States, Canada, and the United Kingdom can significantly increase Synergy CHC Corp.'s product visibility and accessibility. Collaborating with retailers like Walmart, Target, and Boots can provide access to a broader customer base and enhance brand recognition. These partnerships can drive sales volume and market share. Timeline: Upcoming, within the next 12-24 months.
• Enhanced Online Presence and E-commerce Strategy: Investing in a robust e-commerce platform and digital marketing strategy can improve Synergy CHC Corp.'s online sales and customer engagement. Optimizing the company's website, utilizing social media marketing, and implementing targeted advertising campaigns can attract new customers and drive online revenue. The global e-commerce market is expected to reach $6.3 trillion in 2024. Timeline: Ongoing.
• Product Innovation and New Product Development: Developing innovative and differentiated products can help Synergy CHC Corp. stand out in the competitive consumer health and wellness market. Investing in research and development to create new formulations, address emerging health trends, and cater to specific consumer needs can drive growth and enhance brand loyalty. Timeline: Ongoing.
• Geographic Expansion: Expanding into new geographic markets can provide Synergy CHC Corp. with significant growth opportunities. Targeting countries with growing economies and increasing demand for consumer health and wellness products, such as emerging markets in Asia and Latin America, can drive revenue growth and diversify the company's customer base. Timeline: Potential, within the next 3-5 years.

What Are SNYR's Competitive Advantages?

• Brand recognition for FOCUSfactor in the brain health supplement market.
• Established distribution network across multiple channels (retail, online, television).
• Proprietary formulations and product development capabilities.

What Does SNYR Do?

Synergy CHC Corp., established in 2010 and based in Westbrook, Maine, focuses on developing and distributing consumer health care, beauty, and lifestyle products. Originally incorporated as Synergy Strips Corp., the company rebranded to Synergy CHC Corp. in August 2015 to reflect its expanded product portfolio. The company's core offerings include brain health nutritional supplements under the FOCUSfactor brand, which aims to enhance cognitive function. Additionally, Synergy CHC Corp. markets lifestyle products and accessories under the Flat Tummy brand, featuring items such as tea, shakes, lollipops, supplements, apparel, and exercise accessories. The company also offers anti-aging skincare products under the Hand MD brand, including serums, creams, hand soaps, and sanitizers designed for skin repair, rehydration, and overall hand care. Synergy CHC Corp. distributes its products through a multi-channel approach, leveraging retailers, television advertising campaigns, and online sales platforms to reach consumers in the United States, Canada, and the United Kingdom. The company aims to cater to health-conscious consumers seeking accessible and effective solutions in the health, beauty, and lifestyle sectors.

What Products and Services Does SNYR Offer?

• Develops and markets brain health nutritional supplements under the FOCUSfactor brand.
• Offers lifestyle products and accessories under the Flat Tummy brand, including teas, shakes, and apparel.
• Provides anti-aging skincare products under the Hand MD brand, such as serums and creams.
• Sells products through retailers in the United States, Canada, and the United Kingdom.
• Utilizes television advertising campaigns to promote its products.
• Distributes skincare products through online channels.

How Does SNYR Make Money?

• Develops and markets consumer health, beauty, and lifestyle products.
• Generates revenue through retail sales, online sales, and television advertising.
• Focuses on brand development and marketing to drive product demand.

What Industry Does SNYR Operate In?

Synergy CHC Corp. operates within the competitive consumer health and wellness industry, which includes dietary supplements, skincare, and lifestyle products. The market is characterized by evolving consumer preferences, increasing demand for natural and organic products, and intense competition from established players and emerging brands. The global dietary supplements market is projected to reach $230.73 billion by 2027, growing at a CAGR of 9.6%. Synergy CHC Corp. competes with companies offering similar products through retail, online, and direct-to-consumer channels. The company's success depends on effective marketing, product innovation, and strategic partnerships to gain market share.

Who Are SNYR's Key Customers?

• Health-conscious consumers seeking brain health supplements.
• Individuals interested in lifestyle products and accessories.
• Consumers looking for anti-aging skincare solutions.

Company Profile

Synergy CHC Corp. operates in the Medical - Distribution industry within the Healthcare sector. It is headquartered in Westbrook, US. The company is led by CEO Jack Ross. SNYR has traded publicly since 2014.

Return on equity for Synergy CHC Corp. stands at 91.3%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.93 means current liabilities exceed short-term assets, a liquidity point worth watching.

SNYR Valuation & Market Position

With a $1.21M market cap, Synergy CHC Corp. sits in the micro-cap segment of the market. Relative to its peer group, SNYR's quantitative score of 20/100 is below the peer average of 47/100.

Quarterly Financial Performance: Synergy CHC Corp.

Revenue for Synergy CHC Corp. came in at $5.5M during Q1 2026, a 9.4% contraction versus the preceding quarter. The company recorded a net loss of $2.6M, with diluted EPS of $-0.23. Revenue has contracted over three consecutive quarters, which investors in this micro-cap Healthcare stock should monitor closely. Across the four most recent quarters, SNYR averaged $-0.40 in diluted EPS.

Synergy CHC Corp.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -13.08 places it in the distress zone, a signal of elevated financial risk.

Synergy CHC Corp. has missed Wall Street's EPS estimate in 3 of its last 7 reported quarters — a mixed record worth weighing. Reported results have landed about 571.6% below estimates on average.

Wall Street analysts project Synergy CHC Corp. revenue of about $32.0M for fiscal 2026, with EPS near $-0.19.

SNYR Financials

SNYR Latest News

SNYR Analyst Consensus

SNYR MoonshotScore

Common Questions About SNYR (Healthcare)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources